Genaera to Present at Therapeutic Area Partnerships 2008
PLYMOUTH MEETING, Pa., October 30, 2008 /PRNewswire-FirstCall/ -- Genaera Corporation will present at the Windhover's Therapeutic Area Partnerships Conference being held November 3-5 at the Lowes Hotel in Philadelphia, Pennsylvania. Dr. Henry Wolfe, Executive Vice President and Chief Scientific Officer, will provide an overview on MSI-1436 for the treatment of type 2 diabetes and obesity on Tuesday, November 4, 2008 at 4:20 p.m. (ET).
Genaera Corporation is developing trodusquemine (MSI-1436), for type 2 diabetes and obesity currently in phase 1 clinical testing and has a fully out-licensed partnership with MedImmune, Inc. that is in phase 2 clinical testing in asthma. For further information, please see our website at .
CONTACT: investors, Genaera Corporation, +1-610-941-5675, or media,Shirley Chow, Porter Novelli Life Sciences, +1-212-601-8308, schow@pnlifesciences.com
Web site: http://www.genaera.com/
Ticker Symbol: (NASDAQ-NMS:GENR)
Terms and conditions of use apply
Copyright © 2008 PR Newswire Association LLC. All rights reserved.
A United Business Media Company
Posted: October 2008
